Stock Chart

TEVA

$43.65 +0.95%
Score: 36.1 AVOID NEW MONEY
LEAPs: SELL $32
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $32
Premium: $2.99
Expiry: Jan 15, 2027
Target: $27
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 1.33x (vs SPY: 1.8x | vs QQQ: 1.9x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 12, 2026
Rising Channel weak / forming — below our quality gate quality 51/100
A Rising Channel is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Lower rail breaks first 80% of the time (n=1,744) — a trend-exit tell, not a crash call
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About TEVA - Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar …

Key Statistics

Market Cap $50B
P/E Ratio 100.56

This TEVA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track TEVA's price movements with trendlines, gamma walls, and key support/resistance levels.